AMBRX Trademark

Trademark Overview

On Wednesday, January 18, 2006, a trademark application was filed for AMBRX with the United States Patent and Trademark Office. The USPTO has given the AMBRX trademark a serial number of 78793627. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, July 28, 2017. This trademark is owned by Ambrx, Inc.. The AMBRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of protein engineering; scientific and industrial research; research in genetic, medical, pharmaceutical and chemistry fields; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology [, agriculture ]; scientific research, namely, studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology
ambrx

General Information

Serial Number78793627
Word MarkAMBRX
Filing DateWednesday, January 18, 2006
Status800 - REGISTERED AND RENEWED
Status DateFriday, July 28, 2017
Registration Number3255195
Registration DateTuesday, June 26, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2007

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 1, "CALIFORNIA" should be deleted, and "DELAWARE" should be inserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDevelopment of new technology for others in the field of protein engineering; scientific and industrial research; research in genetic, medical, pharmaceutical and chemistry fields; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology [, agriculture ]; scientific research, namely, studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2006
Primary Code042
First Use Anywhere DateTuesday, April 13, 2004
First Use In Commerce DateTuesday, April 13, 2004

Trademark Owner History

Party NameAmbrx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAmbrx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAmbrx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Wednesday, March 10, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, February 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 30, 2021TEAS SECTION 7 REQUEST RECEIVED
Monday, January 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 23, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 23, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 28, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, July 28, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, July 28, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, July 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 21, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, June 26, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 17, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 17, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 12, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Friday, July 12, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, July 12, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 26, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 21, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 21, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 26, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, April 10, 2007PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2007NOTICE OF PUBLICATION
Saturday, February 24, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 24, 2007ASSIGNED TO LIE
Friday, January 19, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 17, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 4, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2006NON-FINAL ACTION E-MAILED
Monday, July 17, 2006NON-FINAL ACTION WRITTEN
Friday, July 7, 2006ASSIGNED TO EXAMINER
Wednesday, January 25, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, January 24, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

ambrx genetic research design engineering protein biotechnology molecular biology fields veterinary